Elsevier

European Journal of Radiology

Volume 86, January 2017, Pages 361-370
European Journal of Radiology

Pulmonary MR angiography and perfusion imaging—A review of methods and applications

https://doi.org/10.1016/j.ejrad.2016.10.003Get rights and content

Highlights

  • This article represents an overview of the methodology and clinical applications of pulmonary MRA and perfusion imaging.

  • Both contrast enhanced and non-contrast enhanced metholodology for MRA and perfusion are covered.

  • The current clinical uses and future directions of MRA and MR perfusion are discussed.

Abstract

The pulmonary vasculature and its role in perfusion and gas exchange is an important consideration in many conditions of the lung and heart. Currently the mainstay of imaging of the vasculature and perfusion of the lungs lies with CT and nuclear medicine perfusion scans, both of which require ionizing radiation exposure. Improvements in MRI techniques have increased the use of MRI in pulmonary vascular imaging. Here we review MRI methods for imaging the pulmonary vasculature and pulmonary perfusion, both using contrast enhanced and non-contrast enhanced methodology.

In many centres pulmonary MR angiography and dynamic contrast enhanced perfusion MRI are now well established in the routine workflow of patients particularly with pulmonary hypertension and thromboembolic disease. However, these imaging modalities offer exciting new directions for future research and clinical use in other respiratory diseases where consideration of pulmonary perfusion and gas exchange can provide insight in to pathophysiology.

Introduction

The role of the respiratory system is to ensure adequate exchange of oxygen and carbon dioxide for the body’s metabolic requirements. This process of gas exchange requires adequate ventilation, passive diffusion across the alveolar surface and pulmonary perfusion. The assessment of pulmonary perfusion is therefore important in further understanding multiple physiological and pathophysiological mechanisms and also in the diagnosis and follow up of multiple pulmonary diseases.

There are two broad approaches in MR imaging of the pulmonary circulation. Higher spatial, but lower temporal resolution MR angiography (MRA) allows for assessment of the structure of the pulmonary arterial and venous system. Whilst lower spatial but higher temporal resolution perfusion MRI allows for the assessment of capillary level tissue perfusion [1] (Fig. 1).

Current clinical practice relies upon CTPA for the structural analysis of the pulmonary vasculature: it is readily available, fast, cheap and offers high spatial resolution. However, it requires exposure to approximately 5 mSv of ionising radiation, which is associated with increased risk of cancer and requires the use of iodinated contrast media, which is contraindicated in allergy or renal failure. Single photon emission computed tomography (SPECT) is currently the mainstay of clinical perfusion imaging. This requires injection of 100MBq of 99mTc labelled macro-aggregated human albumin, resulting in exposure to ionising radiation with an effective dose of 3 mSv [2]. Beyond exposure to ionising radiation the limitations of SPECT include: low spatial and temporal resolution, soft tissue attenuation (for example breast tissue or obesity) and movement from the diaphragm.

Historically, pulmonary MRI has been limited by poor signal due to: low proton density; susceptibility differences between multiple air-tissue interfaces causing short T2*; and motion artefact from the heart and breathing [1], [3], [4]. However, improvements in scanner hardware and short echo time pulse sequences combined with parallel imaging and view sharing techniques have allowed for reduced acquisition times, counteracting the short T2* and movement artefacts. Imaging of pulmonary perfusion and particularly its quantification is further complicated by a number of physiological processes. There are physiological differences in pulmonary blood flow in expiration and inspiration [1]. Furthermore there are anatomical differences in regional perfusion due to gravity, causing an apico-basal gradient when erect [5] or an antero-posterior gradient when supine [6]. This perfusion heterogeneity is reduced in the prone position [7]. Consideration is also required of the dual circulatory systems in the lungs: the pulmonary arteries carry deoxygenated blood from the right ventricle to the lungs to be oxygenated and the bronchial arteries carry oxygenated blood from the aorta to supply the pulmonary parenchyma with its metabolic requirements [1]. Moreover, the pulmonary arteries and veins have a similar anatomical distribution and can be hard to distinguish so it is therefore important to ensure that the correct “phase” of blood flow is imaged. MRI of the lungs is also further constrained by patient factors: patients who are short of breath may not be able to breath-hold for much longer than 10 s and patient positioning and claustrophobia can also lead to scanning difficulties with movement artefacts or abortion of scans.

Section snippets

Contrast enhanced MRA

T1 shortening contrast agents can be used to produce high spatial resolution images of the pulmonary arteries and veins with 3D acquisitions within a single breath-hold. Currently this method is the mainstay of pulmonary MRA in the clinical setting. Typically, a bolus of gadolinium-chelated agent is administered into a large vein, usually in the antecubital fossa followed by a saline flush. Typical contrast doses are 0.1 mmol/kg body weight Gadovist followed by a 20 ml saline flush injected at 5 

Non-contrast enhanced MRA and perfusion imaging

Long acquisition times and problems with artefacts, such as motion, have limited the use of non-contrast enhanced MRA. Improving MR technologies, concerns about the use of gadolinium from the risk of nephrogenic systemic fibrosis [17] and the desire for non-invasive techniques for paediatrics have increased the motivation for non-contrast enhanced methodology for MR perfusion and angiography.

Double inversion recovery fast spin echo (DIR FSE) imaging, also known as black blood imaging, provides

Clinical applications of pulmonary MRA and perfusion imaging

An area that has had significant interest for MR angiography and perfusion is in the assessment of pulmonary emboli (PE) [25], particularly in young or pregnant patients who benefit from the avoidance of radiation exposure. Real time MR with SSFP (True FISP) produces T2 weighted images in which blood in the pulmonary arteries is bright and thrombus is dark. A major advantage of this method is that it is unaffected by patient movement. A study of 39 cases with suspected PE gave sensitivity of

Conclusion

Improvements in MRI technology have triggered increasing interest in pulmonary MR perfusion and angiography. Whilst multiple methods of image acquisition are available, the mainstay of current clinical use is contrast enhanced MRA and DCE MRI. Modest concerns regarding the widespread use of gadolinium based contrast agents and the requirement for IV access have increased interest in non-contrast enhanced techniques, although these methods are currently confined to research. Pulmonary MRA and

Conflicts of interest

No conflicts of interest.

References (61)

  • J. Du et al.

    High-resolution time-resolved contrast-enhanced MR abdominal and pulmonary angiography using a spiral-TRICKS sequence

    Magn. Reson. Med. [Internet]

    (2007)
  • N.D. Abolmaali et al.

    Gadomer-17-enhanced 3D navigator-echo MR angiography of the pulmonary arteries in pigs

    Eur. Radiol. [Internet]

    (2002)
  • K.L. Li et al.

    Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors

    J. Magn. Reson. Imaging [Internet]

    (2000)
  • F. Risse

    MR perfusion of the lung [Internet]

  • P. Meier et al.

    On the theory of the indicator-dilution method for measurement of blood flow and volume

    J. Appl. Physiol. [Internet]

    (1954)
  • Y. Ohno et al.

    Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects

    J. Magn. Reson. Imaging [Internet]

    (2004)
  • S. Ley et al.

    Pulmonary perfusion imaging using MRI: clinical application

    Insights Imaging [Internet]

    (2012)
  • F. Risse et al.

    Dual-bolus approach to quantitative measurement of pulmonary perfusion by contrast-enhanced MRI

    J. Magn. Reson. Imaging

    (2006)
  • H. Köstler et al.

    Prebolus quantitative MR heart perfusion imaging

    Magn. Reson. Med. [Internet]

    (2004)
  • R. Agarwal et al.

    Gadolinium-based contrast agents and nephrogenic systemic fibrosis: a systematic review and meta-analysis

    Nephrol. Dial. Transplant.

    (2009)
  • M. Miyazaki et al.

    Nonenhanced MR angiography

    Radiology [Internet]

    (2008)
  • R. Bitar et al.

    MR pulse sequences: what every radiologist wants to know but is afraid to ask

    RadioGraphics [Internet]

    (2006)
  • S. Rajaram et al.

    Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension

    Eur. Radiol. [Internet]

    (2012)
  • O. Bieri

    Ultra-Fast steady state free precession and its application to In vivo 1H morphological and functional lung imaging at 1.5 tesla

    Magn. Reson. Med.

    (2013)
  • P. Martirosian et al.

    Magnetic resonance perfusion imaging without contrast media

    Eur. J. Nucl. Med. Mol. Imaging

    (2010)
  • Y. Gao et al.

    Arterial spin labeling – fast imaging with steady-state free precession (ASL-FISP): a rapid and quantitative perfusion technique for high field MRI

    NMR Biomed.

    (2014)
  • A. Fischer et al.

    Assessment of pulmonary perfusion in a single shot using SEEPAGE

    J. Magn. Reson. Imaging [Internet]

    (2008)
  • E.J.R. Van Beek et al.

    MRI for the diagnosis of pulmonary embolism

    J. Magn. Reson. Imaging

    (2003)
  • A.J. Barker et al.

    Four-dimensional flow assessment of pulmonary artery flow and wall shear stress in adult pulmonary arterial hypertension: results from two institutions

    Magn. Reson. Med. [Internet]

    (2015)
  • M. Markl et al.

    4D flow MRI

    J. Magn. Reson. Imaging

    (2012)
  • Cited by (34)

    • A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19

      2021, The Lancet Respiratory Medicine
      Citation Excerpt :

      However, considering the small size of the vessels supplying the area of lung occupied by ground glass opacities, visualisation of PIC-induced clots is limited by the resolution constraints of CT, although clots can be easily identified at post-mortem. Despite the spatial limitation of CTPA in detecting microemboli or microthrombi, magnetic resonance pulmonary perfusion and single-photon emission CT (SPECT) pulmonary perfusion could potentially show the small areas of hypoperfusion secondary to PIC (and at the same time could also confirm or exclude pulmonary embolism to large and medium-sized arteries).37,38 Moreover, the alveolar tropism of betacoronavirus and the functional integration of alveoli with the capillary network and adjacent small vessels distinguishes COVID-19 from the disease caused by other respiratory viruses, including influenza and respiratory syncytial virus, which show more proximal airway involvement with discrete pathological mechanisms (figure 1C).

    View all citing articles on Scopus
    View full text